The first daily pill for treating endometriosis symptoms has been approved for use on the NHS in England - but only for ...

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, ...

Crizanlizumab (Adakveo) failed to outperform placebo in patients with sickle cell disease, the phase III STAND trial showed.

The drug will only be made available on the NHS for patients whose medical or surgical treatment for endometriosis has failed ...

The measure, which passed with bipartisan support and minor changes, now heads back to the House. It is just the second ...

A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

Massachusetts residents are sick and tired of paying taxes, and a new poll shows strong opposition from likely voters on Gov.

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...